Sickle Cell Disease Newborn Screening Follow-Up Program
HRSA-17-079 | Maternal & Child Health Bureau
Application Accepted: 09/09/2016 to 11/10/2016
Projected Award Date: 06/01/2017
Estimated Award Amount: N/A
This announcement solicits applications for the Sickle Cell Disease Newborn Screening Follow-Up Program (SCDNBSFP) to provide support for a Sickle Cell Newborn Screening Technical Assistance Center (TAC) that will improve the care and reduce rates of loss to follow-up of individuals identified with sickle cell disease (SCD) and sickle cell trait through universal newborn screening by supporting efforts of community-based organizations (CBOs) on sickle cell disease education and service coordination. This program will enhance sickle cell CBOs’ ability to ensure that individuals diagnosed with sickle cell disease through newborn screening receive appropriate follow-up services including counseling, education, access to a medical home, and other support services. The primary population focus should be families of individuals identified with sickle cell disease and trait through newborn screening.
Per 42 CFR § 51a.3 (a), any public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 450b) is eligible to apply. Faith-based and community-based organizations are eligible to apply.
Foreign entities are not eligible for HRSA awards, unless the authorizing legislation specifically authorizes awards to foreign entities or the award is for research. This exception does not extend to research training awards or construction of research facilities.